000 01281 a2200325 4500
005 20250514003012.0
264 0 _c20010906
008 200109s 0 0 eng d
022 _a0165-6147
024 7 _a10.1016/s0165-6147(00)01713-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSzyf, M
245 0 0 _aTowards a pharmacology of DNA methylation.
_h[electronic resource]
260 _bTrends in pharmacological sciences
_cJul 2001
300 _a350-4 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aCell Cycle
_xdrug effects
650 0 4 _aDNA (Cytosine-5-)-Methyltransferase 1
650 0 4 _aDNA (Cytosine-5-)-Methyltransferases
_xantagonists & inhibitors
650 0 4 _aDNA Methylation
_xdrug effects
650 0 4 _aGene Expression
_xdrug effects
650 0 4 _aHumans
650 0 4 _aOligonucleotides, Antisense
_xpharmacology
650 0 4 _aOxidoreductases, O-Demethylating
_xdrug effects
650 0 4 _aTumor Cells, Cultured
_xdrug effects
773 0 _tTrends in pharmacological sciences
_gvol. 22
_gno. 7
_gp. 350-4
856 4 0 _uhttps://doi.org/10.1016/s0165-6147(00)01713-2
_zAvailable from publisher's website
999 _c11360334
_d11360334